Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/21/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Gordon Chiu

Wrong Dr. Gordon Chiu?
 
Background

Employment History

Board Memberships and Affiliations

Education

  • BS degree summa cum laude , chemistry
    Rensselaer Polytechnic Institute
  • MS degree with honors , chemistry
    Seton Hall University
  • MD/PhD candidate
    Mount Sinai School of Medicine
  • B.S. degree summa cum laude , chemistry
    Rensselaer Polytechnic Institute
  • M.S. degree with honors , chemistry
    Seton Hall University
120 Total References
Web References
Graphene may even replace some ...
www.entrepreneur.com, 21 Dec 2014 [cached]
Graphene may even replace some metals and other natural resources mined for manufacturing, says Gordon Chiu, founder, president and CTO of Grafoid and co-inventor of MesoGraf.
"Imagine taking something that was 100 percent oil-dependent and making it only 50 percent oil-dependent by mixing in graphene. Not only is the product lighter and stronger, but it's also safer for the environment," Chiu says.
Dr. Gordon Chiu, B.Sci, ...
www.focusgraphite.com, 22 Nov 2014 [cached]
Dr. Gordon Chiu, B.Sci, M.Sci, MSTP recipient, ND
Chief Scientist
Dr. Gordon Chiu is Focus Graphite's Chief Scientist and is Vice-President and co-founder of Grafoid Inc., Focus Graphite's joint venture to develop, patent and secure the global rights for specific graphene technologies.
Described as an "execution-driven businessman," Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries. A lecturer and corporate advisor, Dr. Chiu is engaged in the discovery and research of graphene on behalf of Grafoid and provides advice on project selection with a view to increasing overall shareholder value.
Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia. He holds a BS degree summa cum laude in chemistry from Rensselaer Polytechnic Institute; graduated with an MS degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program at the Mount Sinai School of Medicine. He jointly combined his cumulative training with an ND degree in naturopathic medicine from the University of Bridgeport.
Graphite Stocks | Focus Graphite
graphitestocks.com, 19 Dec 2013 [cached]
Dr. Gordon Chiu, B.Sci, M.Sci, MSTP recipient, ND.
Dr. Gordon Chiu is Vice President and Chief Scientist of Grafoid inc., Focus Metals' joint venture to develop, patent and secure the global rights for specific graphene technologies. The joint venture is based in New York City.
Described as an "execution-driven businessman," Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries. A lecturer and corporate advisor, Dr Chiu is engaged in the discovery and research of graphene on behalf of Grafoid and provides advice on project selection with a view to increasing overall shareholder value.
Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia. He holds a B.S. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute; graduated with an M.S. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program at the Mount Sinai School of Medicine. He jointly combined his cumulative training with an ND degree in naturopathic medicine from the University of Bridgeport.
Dr. Gordon Chiu, B.Sci., ...
www.grafoid.com, 5 Oct 2014 [cached]
Dr. Gordon Chiu, B.Sci., MSci, f-MSTP, ND
President, Chief Technology Officer, Director and Founding Partner
Described as an "execution-driven businessman," Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries. As President, Chief Technology Officer and co-founder of Grafoid Inc., Dr. Chiu is engaged in the discovery and research of graphene on behalf of Grafoid, as well as the development of graphene applications with Grafoid's joint venture application development partners. He is also Focus Graphite Inc.'s Chief Scientist. Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia. Dr. Chiu holds a B.Sc. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute, graduated with a M.Sc. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program (MSTP) at the Mount Sinai School of Medicine. Dr. Chiu jointly combined his cumulative training with a Doctor of Naturopathic Medicine (ND) degree from the University of Bridgeport.
Grafoid's technology - ...
www.grafoid.com, 5 Oct 2014 [cached]
Grafoid's technology - developed by the National University of Singapore and Grafoid's President, Chief Technology Officer and Founding Partner, Dr. Gordon Chiu - produces pristine, high-energy density MesoGraf™ functional graphene at significant gross margins.
...
Grafoid's 50% owned subsidiary, Graphite Zero Pte Ltd. is a private Singapore-based graphene research, development and manufacturing company, managed by the equity participation of Professor Loh Kian Ping, Dr. Chiu and Focus Graphite. Graphite Zero has entered into an exclusive agreement with the National University of Singapore to help commercialize graphene products using the patent-pending, simple low-cost process developed by the National University of Singapore's Graphene Research Centre and Grafoid's President, Chief Technology Officer and Founding Partner, Dr. Gordon Chiu.
National University of Singapore's Graphene Research Centre
The National University of Singapore's world-renowned Graphene Research Centre was created in 2010 for the conception, characterization, theoretical modeling, and development of transformative technologies based on graphene and is the IP holder of the MesoGraf™ production process. MesoGraf™ was developed by inventors Dr. Gordon Chiu, President, Chief Technology Officer and Founding Partner of Grafoid, and by Professor Loh Kian Ping of the National University of Singapore's (NUS) Graphene Research Centre. Research, pilot process and manufacturing are done in partnership with Graphite Zero, the University's first commercial graphene spinout company.
Other People with the name "Chiu":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.